CCMH
SCMP

Cornerstone Capital Management Holdings’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2.05M Buy
114,300
+6,700
+6% +$82.5K 0.01% 755
2017
Q3 		$1.27M Sell
107,600
-51,400
-32% -$577K 0.01% 880
2017
Q2 		$1.67M Sell
159,000
-266,200
-63% -$2.71M 0.01% 782
2017
Q1 		$4.68M Buy
425,200
+162,800
+62% +$1.89M 0.04% 482
2016
Q4 		$3.56M Buy
262,400
+106,400
+68% +$1.48M 0.03% 572
2016
Q3 		$1.92M Buy
156,000
+48,800
+46% +$575K 0.01% 772
2016
Q2 		$1.18M Sell
107,200
-57,200
-35% -$640K 0.01% 863
2016
Q1 		$1.8M Buy
164,400
+129,500
+371% +$1.64M 0.02% 773
2015
Q4 		$604K Buy
34,900
+28,100
+413% +$504K 0.01% 999
2015
Q3 		$135K Sell
6,800
-2,400
-26% -$55K ﹤0.01% 1286
2015
Q2 		$151K Buy
9,200
+1,600
+21% +$27.7K ﹤0.01% 1243
2015
Q1 		$118K Sell
7,600
-67,600
-90% -$1.05M ﹤0.01% 1252
2014
Q4 		$1.07M Sell
75,200
-25,200
-25% -$266K 0.01% 868
2014
Q3 		$653K Buy
100,400
+15,000
+18% +$99.6K 0.01% 938
2014
Q2 		$589K Buy
85,400
+61,800
+262% +$437K 0.01% 957
2014
Q1 		$169K Sell
23,600
-4,500
-16% -$38.5K ﹤0.01% 1137
2013
Q4 		$264K Buy
28,100
+1,900
+7% +$13.6K ﹤0.01% 1016
2013
Q3 		$163K Buy
26,200
+16,400
+167% +$102K ﹤0.01% 1077
2013
Q2 		$65K Buy
+9,800
New +$77.7K ﹤0.01% 1163

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Cornerstone Capital Management Holdings's SCMP Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Sucampo Pharmaceuticals, Inc. (SCMP) stake by 6.2% in Q4 2017, buying an estimated $82.5K and bringing the position to 114,300 shares worth $2.05M. The position accounts for 0.01% of the portfolio, ranked #755.

Cornerstone Capital Management Holdings first reported a position in SCMP in Q2 2013 and has held it in 19 quarters since. The position peaked at $4.68M in Q1 2017. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

  • Cornerstone Capital Management Holdings held 114,300 shares of Sucampo Pharmaceuticals, Inc. worth $2.05M as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 6,700 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $82.5K.
  • Sucampo Pharmaceuticals, Inc. made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #755 holding.
  • Cornerstone Capital Management Holdings first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and has held it in 19 quarters since.
  • Cornerstone Capital Management Holdings's Sucampo Pharmaceuticals, Inc. position peaked at $4.68M in Q1 2017.
  • 188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.